Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma.

Martin D. McCarter,Richard P. Tobin,Dasha T Cogswell,Victoria M. Vorwald,Dana Davis,Robert J. Van Gulick,Kasey L. Couts,Kimberly R. Jordan,Victoria Nuanes,Dexiang Gao,Theresa Medina,Karl D. Lewis,Rene Gonzalez,Ross W. McFarland,William A. Robinson

Pembrolizumab and all-trans retinoic acid combination treatment of advanced melanoma.

2021

Martin D. McCarter
Richard P. Tobin
Dasha T Cogswell
Victoria M. Vorwald
Dana Davis
Robert J. Van Gulick
Kasey L. Couts
Kimberly R. Jordan
Victoria Nuanes
Dexiang Gao
Theresa Medina
Karl D. Lewis
Rene Gonzalez
Ross W. McFarland
William A. Robinson

9536Background: Myeloid-derived suppressor cells (MDSCs) are potent suppressors of antitumor immunity and are commonly associated with poor outcomes in melanoma patients treated with immune checkpo...

Keywords:

Cancer research
Retinoic acid
Immune system
Melanoma
advanced melanoma
Medicine
all trans
combined treatment
Pembrolizumab
Suppressor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations